董国良;郏建臣;王玉华;郝静;

• 1:河南科技大学第一附属医院开元院区急诊科

摘要(Abstract)：

目的探讨腔隙性脑梗死患者血清趋化素(Chemerin)、丝氨酸蛋白酶抑制剂(Vaspin)及脂肪素(Apelin)水平及意义。方法选取2018-01—2019-03在河南科技大学第一附属医院治疗的腔隙性脑梗死患者120例(观察组),其中轻度32例,中度61例,重度27例,同时选取健康志愿者100例为对照组,检测2组血清Chemerin、Vaspin和Apelin,观察组给予常规治疗。结果观察组血清Chemerin和Apelin分别为(60.03±10.02)mg/L和(180.02±41.12)μg/L,明显高于对照组(P<0.05),而Vaspin为(6.72±1.01)μg/L,明显低于对照组(P<0.05);观察组重度患者血清Chemerin和Apelin分别为(72.44±13.30)mg/L和(209.34±50.28)μg/L,明显高于轻度和中度患者(P<0.05),而Vaspin为(4.23±0.92)μg/L,明显低于轻度和中度患者(P<0.05);中度患者血清Chemerin和Apelin分别为(62.22±12.28)mg/L和(180.02±41.18)μg/L,明显高于轻度患者(P<0.05),而Vaspin为(6.72±1.09)μg/L,明显低于轻度患者(P<0.05);Chemerin和Apelin与DNS评分呈正相关(r=0.332、0.319,P<0.05),而Vaspin与DNS评分呈负相关(r=-0.422,P<0.05);观察组治疗后血清Chemerin和Apelin较治疗前降低(P<0.05),而Vaspin较治疗前升高(P<0.05)。结论腔隙性脑梗死患者血清Chemerin和Apelin明显升高,而Vaspin明显降低,与神经功能缺损程度有一定关系。

关键词(KeyWords)： 腔隙性脑梗死;趋化素;丝氨酸蛋白酶抑制剂;脂肪素

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 董国良;郏建臣;王玉华;郝静;

参考文献(References)：

• [1] ATESA H,ARSLAN U,AKSAKAL A,et al.Plasma Chemerin Levels Are Increased in ST Elevation Myocardial Infarction Patients with High Thrombus Burden[J].Cardiol Res Pract,2018,2018(10):1-5.DOI:10.1155/2018/5812704.
• [2] WYSKIDA K,FRANIK G,WIKAREK T,et al.The levels of adipokines in relation to hormonal changes during the menstrual cycle in young,normal-weight women[J].Endocr Connect,2017,6(8):892-900.DOI:10.1530/EC-17-0186.
• [3] MONTAZERIFAR F,BAKHSHIPOUR A R,KARAJIBANI M,et al.Serum omentin-1,Vaspin,and Apelin levels and central obesity in patients with nonalcoholic fatty liver disease[J].J Res Med Sci,2017,22(1):70-72.DOI:10.4103/jrms.JRMS_788_16.
• [4] MOTAWI T K,MAHDY S G,ELSAWALHI M M,et al.Serum Levels of Chemerin,Apelin,Vaspin and Omentin-1in Obese Type 2Diabetic Egyptian Patients with Coronary Artery Stenosis[J].Can J Physiol Pharmacol,2017,96(1):38-40.DOI:10.1139/cjpp-2017-0272
• [5] LI X,HAN X,HUA Y,et al.Correlation between cerebral blood flow and cerebral infarction in patients with chronic middle cerebral artery occlusion detected by ultrasound[J].Chin J Cerebrovasc Dis,2017,14(5):245-249.DOI:10.3969/j.issn.1672-5921.2017.05.005.
• [6] SHIMODA Y,OHTOMO S,ARAI H,et al.Subarachnoid small vein occlusion due to inflammatory fibrosisbrosisosisibrosisents with chronic middle cerebral cryptococcal meningoencephalitis:a case report[J].BMC Neurol,2017,17(1):157-159.DOI:10.1186/s12883-017-0934-y.
• [7] ZHANG X Y,LIU Y,HE T,et al.Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in3T3-L1adipocytes.[J].Biomed Pharmacother,2018,103(8):955-964.DOI:10.1530/EC-17-0186.
• [8] POLAK K,CZYZYK A,SIMONCINI T,et al.New markers of insulin resistance in polycystic ovary syndrome[J].J Endocrinol Invest,2017,40(1):1-8.DOI:10.1007/s40618-016-0523-8.
• [9] NOMANI H,KHANMOHAMADIAN H,VAISIRAYGANI A,et al.Chemerin rs17173608and Vaspin rs2236242gene variants on the risk of end stage renal disease(ESRD)and correlation with plasma malondialdehyde(MDA)level[J].Ren Fail,2018,40(1):350-356.DOI:10.1080/0886022X.2018.1459698.
• [10] YANG W,LI Y,TIAN T,et al.Serum Vaspin concentration in elderly patients with type 2diabetes mellitus and macrovascular complications[J].BMC Endocr Disord,2017,17(1):67-68.DOI:10.1186/s12902-017-0216-0.
• [11] STANCíK M,SáGOVá I,KANTOROVá E,et al.The role of Vaspin as a predictor of coronary angiography result in SCAD(stable coronary artery disease)patients[J].BMC Cardiovasc Disord,2017,17(1):117-118DOI:10.1186/s12872-017-0550-1.
• [12] ALKURAISHY H M,ALGAREEB A I,ALBUHADILLY A K.Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome[J].Diseases,2018,6(1):9-10.DOI:10.3390/diseases6010009.
• [13] VINK R G,ROUMANS N J,MARIMAN E C,et al.Dietary weight loss-induced changes in RBP4,FFA,and ACE predict weight regain in people with overweight and obesity[J].Physiol Rep,2017,5(21):13450-13451.DOI:10.14814/phy2.13450.
• [14] SONG T J,KIM J,SONG D,et al.Total Cerebral Small-Vessel Disease Score is Associated with Mortality during Follow-Up after Acute Ischemic Stroke[J].J Clin Neurol,2017,13(2):187-188.DOI:10.3988/jcn.2017.13.2.187.
• [15] LI F,CHEN Q X,CHEN Y,et al.Prevalence and risk factors of microalbuminuria in patients with lacunar infarction[J].Postgrad Med,2019,131(5):342-347.DOI:10.1080/00325481.2019.1613119.
• [16] XU Y,LI Z.Relationship between ABCA1gene polymorphism and lacunar infarction combined with arteriosclerosis in patients[J].Exp Ther Med,2018,16(2):1323-1327.DOI:10.1161/JAHA.118.010653.
• [17] LEE J,KO S.The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea[J].Value Health,2017,20(9):A617-A618.DOI:10.1016/j.jval.2017.08.1242.
• [18] HE Y,WEI L,LI W.Comparison of application values of CT and MRI in the diagnosis of early Lacunar Infarction[J].Pakistan J Med Sci,2018,34(1):190-193.DOI:10.12669/pjms.341.13619.
• [19] PAREKH J M,SHAH P A,SHAH P V,et al.Application of an LC-MS/MS method for the analysis of amlodipine,valsartan and hydrochlorothiazide in polypill for a bioequivalence study[J].J Pharma Anal,2017,7(5):309-316.DOI:10.1016/j.jpha.2017.06.001.
• [20] ZHAO M,DENG X,WANG S,et al.Lacunar infarction in adult patients with moyamoya disease[J].Clin Neurol Neurosurg,2017,164(12):81-82.DOI:10.1016/j.clineuro.2017.10.040.
• [21] UCHIDA H,NIIZUMA K,KUSHIDA Y,et al.Human Muse Cells Reconstruct Neuronal Circuitry in Subacute Lacunar Stroke Model[J].Stroke,2017,48(2):428-435.DOI:10.1161/STROKEAHA.116.014950．
• [22] RUTTENJACOBS L C A,MARKUS H S.Vascular Risk Factor Profiles Differ Between Magnetic Resonance Imaging-Defined Subtypes of Younger-Onset Lacunar Stroke[J].Stroke,2017,48(9):2405-2406.DOI:info:doi/10.1161/STROKEAHA.117.017813.
• [23] XIA C,CHEN H S,WU S W,et al.Etiology of isolated pontine infarctions:a study based on high-reso-lution MRI and brain small vessel disease scores[J].BMC Neurol,2017,17(1):216-217.DOI:10.1186/s12883-017-0999-7.
• [24] LEE W J,JUNG K H,RYU Y J,et al.Progression of Cerebral White Matter Hyperintensities and the Associated Sonographic Index[J].Radiology,2017,284(3):824-833.DOI:10.1148/radiol.2017162064.
• [25] G?K?AL E,NIFTALIYEV E,BARAN G,et al.Progressive deficit in isolated pontine infarction:the association with etiological subtype,lesion topography and outcome[J].Acta Neurologica Belgica,2017,117(3):649-654.DOI:10.1007/s13760-017-0827-2.
• [26] ZHU H,LI Z,LV J,et al.Effects of cerebral small vessel disease on the outcome of patients with ischemic stroke caused by large artery atherosclerosis[J].Neurol Res,2018,40(3):1-10.DOI:10.1080/01616412.2018.1446283.
• [27] MOROZ A A,ABRAMYCHEVA N Y,STEPANOVA M S,et al.Differential diagnosis of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy[J].Zh Nevrol Psikhiatr Im S S Korsakova,2017,117(4):75-80.DOI:10.17116/jnevro20171174175-80.
• [28] KIDA H,SATOH M,II Y,et al.Detection of cerebral amyloid angiopathy by 3-T magnetic resonance imaging and amyloid positron emission tomography in a patient with subcortical ischaemic vascular dementia[J].Psychogeriatrics,2017,17(1):70-72.DOI:10.1111/psyg.12187.